STAT+: FDA approves Rocket gene therapy for rare immune d...

What’s Happening

Real talk: Kresladi has been tested in just nine patients but has had positive results.

The Readout The Readout STAT Plus: Denali Therapeutics, Corcept Therapeutics win FDA approvals By Meghana Keshavan Adams Biotech Scorecard Adams Biotech Scorecard STAT Plus: Allogenes off-the-shelf CAR-T is nearing an early but pivotal study readout By Adam Feuerstein Biotech Biotech STAT Plus: FDA approves Denali Therapeutics drug for Hunter syndrome By Andrew Joseph and Jason Mast Biotech Biotech STAT Plus: Sarepta Therapeutics s rise on early promise for rare disease drugs By Damian Garde The Readout The Readout STAT Plus: Eli Lilly and the ‘societal obligation’ of GLP-1s By Elaine Chen STAT Plus: Automatic enrollment in Medicare Advantage plans under consideration, top Trump health official says By Tara Bannow STAT Plus: How a Texas couple is getting rich off out-of-network medical bills By Tara Bannow STAT Plus: How an outsider crept into Eli Lilly’s top ranks — and plans to drive its business forward By Matthew Herper STAT Plus: A top biotech VC quietly helped Epstein’s ‘solid friend’ make a comeback By Damian Garde STAT Plus: Epic says it has uncovered rot in patient record sharing. (wild, right?)

Why This Matters

Health experts are weighing in on what this means for people.

This is the kind of health news that affects everyday decisions.

The Bottom Line

This story is still developing, and we’ll keep you updated as more info drops.

We want to hear your thoughts on this.